Literature DB >> 25371740

Incidental esophageal submucosal tumor detection by chest radiography: A case report.

Sosuke Tadano1, Tadashi Kondo1, Muneaki Watanabe1, Norio Takayashiki2, Toshihiro Shiozawa3, Gen Ohara3, Kastunori Kagohashi3, Koichi Kurishima3, Hiroaki Satoh3.   

Abstract

Esophageal submucosal tumors are occasionally detected incidentally during a gastrointestinal survey. In the present study, a case of esophageal leiomyoma is reported, which was incidentally detected by chest radiography during an annual survey of mass-screening for lung cancer. The patient underwent a laparoscopic lower esophagectomy, a proximal gastrectomy and a gastric tube reconstruction. Macroscopic examination revealed a 50×40×28-mm mass, while microscopic examination identified submucosal smooth muscle tissue without mitotic activity or necrosis. The tumor was diagnosed as an esophageal leiomyoma. The patient was asymptomatic during the three-month follow-up period. However, when a mass lesion adjacent to the gastrointestinal tract is detected during chest radiography, the possibility of a rare disease should be considered. Therefore, further investigation with upper gastrointestinal radiography and gastroendoscopy should be performed.

Entities:  

Keywords:  chest radiograph; esophageal leiomyoma; esophageal submucosal tumor; mass-screening

Year:  2014        PMID: 25371740      PMCID: PMC4217767          DOI: 10.3892/etm.2014.2008

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


Introduction

Leiomyomas are the most common esophageal mesenchymal neoplasms, even though their occurrence is rare. Patients with esophageal leiomyomas are usually asymptomatic. The most common symptoms, when present, include epigastric discomfort, dysphagia, regurgitation, gastrointestinal bleed, diarrhea and weight loss. Esophageal leiomyomas are occasionally detected incidentally during the examination of other gastrointestinal diseases, of which the majority are identified during endoscopic examination or upper gastrointestinal radiography (1–4). Considering the tumor size and position, patient’s symptoms, general condition and comorbidities, surgical treatment should be determined. In the present study, the case of an esophageal leiomyoma is reported, which was incidentally detected on a plain chest radiograph performed during an annual survey of mass-screening for lung cancer.

Case report

A 55-year-old female was referred to the Mito Medical Center (Mito, Japan) following the detection of a nodule on a chest radiograph performed during an annual survey of mass-screening (Fig. 1). The mass-screening was performed one month prior to this study. The patient did not present any symptoms, such as dysphagia or epigastric pain, had never smoked and had no previous medical history. Physical examination was unremarkable and the results of standard laboratory tests were normal. A chest and abdominal computed tomography (CT) scan (Aquilion 64; Toshiba, Tokyo, Japan) detected a nodule measuring 5 cm in diameter at the distal esophagus, without invading the cardia of the stomach (Fig. 2). An upper gastrointestinal tract radiograph revealed an esophageal submucosal tumor (SMT) at the distal esophagus (Fig. 3), and upper gastrointestinal endoscopy (GIF-H290; Olympus Corporation, Tokyo, Japan) confirmed the diagnosis of an esophageal SMT with a normal mucosa (Fig. 4). Histopathological examination of the tumor biopsy revealed spindle cell proliferation; however, mitotic activity or cellular anaplasia were not detected. Immunohistochemical analysis revealed diffuse and strong positive staining for α-smooth muscle actin (Dako, Tokyo, Japan). No enlargement of the adjacent lymph nodes or evidence of distant metastasis were identified on the chest and abdominal CT scans. The patient was subjected to a laparoscopic lower esophagectomy, a proximal gastrectomy and a gastric tube reconstruction. Macroscopic examination revealed a 50×40×28-mm mass, while microscopic examination identified submucosal smooth muscle tissue without mitotic activity or necrosis (Fig. 5). The patient was asymptomatic during the three-month follow-up period. Written informed patient consent was obtained from the patient.
Figure 1

Mass shadow (arrow) detected on a chest radiograph during a mass-screening program.

Figure 2

Computed tomography scan revealed a mass (arrow) at the distal esophagus.

Figure 3

Upper gastrointestinal tract radiography revealed an esophageal submucosal tumor (arrow) at the distal esophagus.

Figure 4

Upper gastrointestinal endoscopy revealed a submucosal tumor with a normal mucosa.

Figure 5

Images of the resected esophageal submucosal tumor (SMT). (A) Gross inspection of the resected esophageal SMT. (B) Histopathology of the resected tumor (×200; hematoxylin-eosin staining). (C) Immunostaining with α-smooth muscle actin (×100; hematoxylin-eosin staining).

Discussion

Esophageal SMTs are occasionally detected incidentally during the examination of other gastrointestinal diseases (1–4). In these cases, the majority have been identified by upper gastrointestinal tract radiography (2) or endoscopy (1,3,4). Esophageal leiomyomas may appear as a posterior mediastinal mass on chest radiographs (5–7); thus, are identified as an incidental radiographic finding (8,9). In the present study, the right lower lung nodule was initially suspected to be a primary lung cancer tumor, an arteriovenous malformation or a gastrointestinal stromal tumor due to the nodule shape and position. Common symptoms of an esophageal leiomyoma include dysphagia, epigastric pain and retrosternal pain or burning. However, the leiomyoma grows slowly and half of the patients do not present any symptoms unless the tumor is intramural (5,7). Bleeding is common in patients with gastric leiomyomas, whereas esophageal leiomyomas do not ulcerate and rarely bleed (7,10). The patient in the current study did not show any symptoms, such as dysphagia or epigastric pain. The diameter of esophageal leiomyomas has been reported to be <5 cm in 49% of cases, 5–9 cm in 33.7% of cases and >10 cm in 17.3% of cases (11). Several studies have recommended the observation of asymptomatic patients with lesions of <5 cm at the tumor’s largest diameter, as well as when the preoperative analysis excluded malignancy (11,12). However, other studies have reported that malignancy is unable to be completely excluded prior to surgery (5,10). In the present study, the patient did not present any symptoms or evidence of malignancy in the specimens biopsied, although sections of the tumor were >5 cm in diameter. Therefore, a surgical resection of the tumor was performed. Community-based lung cancer screening using chest radiography is well-established in Japan (13–15), allowing residents aged ≥40 years to undergo an annual chest radiography. This screening program has been supported by the Japanese national government under the Health and Medical Services Law for the Aged since 1987 (16). Participants who are suspected of having lung cancer following a chest X-ray or sputum cytology are offered further examinations to confirm the diagnosis during a secondary evaluation. However, a number of diseases other than primary lung tumors have been diagnosed through the mass-screening program, most commonly benign lung, metastatic lung and mediastinal tumors (17–19). To the best of our knowledge, the current study presents the first case of an esophageal leiomyoma detected on a chest radiograph during a mass-screening program. In conclusion, a mass lesion adjacent to the gastrointestinal tract that is detected on a chest radiograph may potentially indicate a rare disease. Therefore, further investigation with upper gastrointestinal radiography and gastroendoscopy should be performed.
  17 in total

Review 1.  Tumors of the esophagus.

Authors:  G F Hatch; L Wertheimer-Hatch; K F Hatch; G B Davis; D K Blanchard; R S Foster; J E Skandalakis
Journal:  World J Surg       Date:  2000-04       Impact factor: 3.352

2.  A case-control study of lung cancer screening in Okayama Prefecture, Japan.

Authors:  K Nishii; H Ueoka; K Kiura; T Kodani; M Tabata; T Shibayama; K Gemba; T Kitajima; A Hiraki; M Kawaraya; T Nakayama; M Harada
Journal:  Lung Cancer       Date:  2001-12       Impact factor: 5.705

3.  Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.

Authors:  M Miettinen; M Sarlomo-Rikala; L H Sobin; J Lasota
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

Review 5.  Benign esophageal schwannoma: report of a case.

Authors:  N Kobayashi; S Kikuchi; H Shimao; Y Hiki; A Kakita; H Mitomi; M Ohbu
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 6.  Granular cell tumors of the esophagus: report of five cases and review of diagnostic and therapeutic techniques.

Authors:  L De Rezende; A J Lucendo; H Alvarez-Argüelles
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

7.  Small benign tumors of the esophagus: radiological diagnosis with double-contrast examination.

Authors:  A Montesi; A Pesaresi; L Graziani; D Salmistraro; L Dini; I Bearzi
Journal:  Gastrointest Radiol       Date:  1983

Review 8.  The spectrum of benign esophageal lesions: imaging findings.

Authors:  Kyung Mi Jang; Kyung Soo Lee; Soon Jin Lee; Eun A Kim; Tae Sung Kim; Daehee Han; Young Mog Shim
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

9.  A case of primary esophageal B-cell lymphoma of MALT type, presenting as a submucosal tumor.

Authors:  Chan Sup Shim; Joon Seong Lee; Jin Oh Kim; Joo Young Cho; Moon Sung Lee; So Young Jin; Wook Youm
Journal:  J Korean Med Sci       Date:  2003-02       Impact factor: 2.153

10.  An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study.

Authors:  H Tsukada; Y Kurita; A Yokoyama; S Wakai; T Nakayama; M Sagawa; H Misawa
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.